logo
Are we willing to drop cash Isas and take more risks with our money?

Are we willing to drop cash Isas and take more risks with our money?

Yahoo2 days ago
Savers are missing out on financial rewards because the benefits of investing in stocks and shares are being drowned out by risk warnings, the chancellor says.
This week Rachel Reeves said savers would be sent details of investment opportunities if they have money in low-interest accounts.
And she won't completely rule out cutting the annual tax-free allowance of cash Individual Savings Accounts (Isas) to push people into stocks and shares Isas instead.
But what are her chances of making the UK a nation of investors, rather than risk-averse savers?
Experts say women are investing less than men, and have warned the chancellor that some of her ideas could backfire and put off potential new investors.
'Pink websites won't work'
Cash savings accounts are steady and safe. The amount of interest varies between account providers, but it is clear how much the returns will be. They are popular when putting money aside for emergencies, or for holidays, a wedding or a car.
By contrast, the value of investments in stocks and shares can go up and down, but with risk can come reward. Long-term investments can be lucrative, not only for individuals, but for the economy as a whole.
Laura Suter, director of personal finance at investment platform AJ Bell, says Reeves and the finance sector should start by making investing more attractive to women.
Having written reports on the Isa gender gap, she argues that, for too long, advertising about investing has been designed by men.
Lisa Caplan, director at investment company Charles Stanley, agrees. "It's not about making your website pink. It's about using less jargon, competitive language, and masculine imagery," she says.
"When clients who are women feel seen and understood, they will be more willing to trust their money to an adviser or even an investment platform. I think this is beginning to change."
Jema Arnold is an investor, and works for UK shareholders' association ShareSoc. She wants investing to be part of general, honest conversation among friends, not private and hidden.
"I go to a book club. I want investing to be like that," she says.
She is joined in a London cafe by Laura Colucci, who is in her 40s, and Wendy Lanham, who is 71. All three are divorcees, who were forced to think about their relationships with money when their marriages ended.
Mrs Arnold was with an investment banker for 17 years. "In many ways I was a traditional housewife," she says. Her now ex-wife had managed that side of the finances.
"I'd switched off that part of my brain when raising a daughter. That was a mistake. I felt foolish. I had to switch it back on again fairly quickly."
Mrs Colucci was the same. "There were investments in my name," she says. "It was a huge learning curve in one year, when I had to take control."
Mrs Lanham put her money into savings accounts. Only later did she consider moving some into investments.
But that was a path that all three initially found difficult to join.
"People froze up and looked awkward when I talked about investing," says Mrs Arnold.
Male domination
Mrs Lanham says she joined a group which met to talk about investing. The membership was entirely male. "I bought myself a book called Investing for Idiots, went to a conference, and treated it like adult education," she says. "I did not know anything, but hung in there, and the organisation changed."
Now, the trio are members of SIGnet – a network of investor groups that meet in different parts of the UK, or online. It is not-for-profit and covers different areas of interest. It has lots of female members.
But they say the chancellor will have little hope of getting more people to invest without initially improving their understanding, especially if they are trying it for the first time.
"There's no point telling people to go and run a marathon when they've never run before," says Mrs Colucci.
Reeves told financial services and business bosses in her Mansion House speech this week that the "negative" narrative around savers investing money in stocks and shares needed to change.
"For too long, we have presented investment in too negative a light, quick to warn people of the risks without giving proper weight to the benefits," she said.
She announced new adverts, reminiscent of the "Tell Sid" campaign of the 1980s, which encouraged people to invest in the newly privatised British Gas.
Targeted messages will also be sent by banks to people who have money in low-interest accounts.
Mrs Suter, from AJ Bell, says this needs to go beyond a "token effort".
"If it can get widespread coverage and enthusiasm, then it could make a difference," she says.
Isa debate
Carol Knight, chief executive of the Investing and Saving Alliance, says Reeves' ambition will be judged a success if more women, more people from ethnic minorities, and more people outside of London become investors.
But Anna Bowes, savings expert at the Private Office, says the chancellor risks her plan backfiring by encouraging people to invest now when markets are jittery due to global uncertainty. That could lead to short-term losses.
"This needs to be done very carefully or it could put off a generation of investors."
And she stresses that forcing people to consider a stocks and shares Isa by reducing the amount that could be put tax-free into a cash Isa would be a huge mistake.
Reeves has stepped back from immediately cutting the tax-free limit on cash Isas, following a backlash from banks and building societies.
But she is still keen to shift some of the £300bn in these accounts to being invested in the UK and its companies, despite "differing views on the right approach".
Any changes would have an impact on millions of people. Isas are incredibly popular - about 42% of UK adults have at least one.
Stocks and shares Isas are less popular but more money is held in them overall - around £431bn, compared to £294bn in cash Isas.
People with Isas are more likely to be older, with estimates suggesting about half of pensioners have one. And while more women have Isas overall, more men have the investment option, with women more likely to stick to the safety of cash.
Many investment companies that sell stocks and shares Isas back a change, while banks and building societies who dominate the cash Isa market are against it.
That debate is likely to pick up again as the chancellor's autumn Budget gets closer.
What is an Isa and how might the rules change?
Savers to be targeted with offers to invest in shares under new plans
One in 10 have no savings, financial regulator says
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Labour announce plans to build £38bn Sizewell C nuclear plant
Labour announce plans to build £38bn Sizewell C nuclear plant

Yahoo

time14 minutes ago

  • Yahoo

Labour announce plans to build £38bn Sizewell C nuclear plant

The government has announced the construction of the Sizewell C nuclear power plant in Suffolk will cost around £38 billion, with it being the biggest equity shareholder in the project. Energy secretary Ed Miliband has signed off on the final investment decision for the development, with the UK government investing a 44.9 per cent stake. New Sizewell C investors include La Caisse with 20 per cent, Centrica with 15 per cent, and Amber Infrastructure with an initial 7.6 per cent. It comes alongside French energy giant EDF announcing earlier this month it was taking a 12.5 per cent stake – lower than its previously stated 16.2 per cent ownership. A general view of main generator 1, at the Sizewell nuclear power plant in Suffolk (James Manning/PA) (PA Archive) The nuclear plant is expected to deliver clean power to the equivalent of six million homes and help save £2bn a year in electricity savings once operational. Rachel Reeves, the chancellor, said the multibillion-pound investment was 'a powerful endorsement of the UK as the best place to do business and as a global hub for nuclear energy'. 'Delivering next generation, publicly owned clean power is vital to our energy security and growth, which is why we backed Sizewell C. This investment will create thousands of good quality jobs and boost the local economy as we deliver on our plan for change,' she said. She later said that the Sizewell C announcement would reduce the UK's reliance on 'foreign dictators' for energy. 'This is something that politicians have spoken about for years and today we are actually delivering,' she told reporters. 'This is a public-private consortium. We as a Government are putting in money but that means that government – taxpayers – will get a return on that investment. The government's statement said the deal ended an 'era of dithering and delay' to give Sizewell C the go-ahead, which will support 10,000 jobs once operational. Mr Miliband said: 'It is time to do big things and build big projects in this country again- and today we announce an investment that will provide clean, homegrown power to millions of homes for generations to come. 'This government is making the investment needed to deliver a new golden age of nuclear, so we can end delays and free us from the ravages of the global fossil fuel markets to bring bills down for good.' Chris O'Shea, Centrica's chief executive, said Sizewell C was a 'compelling investment for our shareholders and the country as a whole'. 'This isn't just an investment in a new power station – it's an investment in Britain's energy independence, our net zero journey, and thousands of high-quality jobs across the country,' he added.

Introducing Latent-X, a Frontier Generative AI Model for Protein Binder Design Accessible via No-Code Platform for Push-Button Protein Design
Introducing Latent-X, a Frontier Generative AI Model for Protein Binder Design Accessible via No-Code Platform for Push-Button Protein Design

Yahoo

time14 minutes ago

  • Yahoo

Introducing Latent-X, a Frontier Generative AI Model for Protein Binder Design Accessible via No-Code Platform for Push-Button Protein Design

Latent-X generates lab-ready macrocycles and protein mini-binders at all-atom resolution to accelerate drug design The model can be accessed through Latent's web-based platform for push-button protein design. Sign ups are open now for early access: Extensive lab validation shows picomolar binding affinities outperforming prior models, with 91-100% hit rates for macrocycles and 10-64% for mini-binders LONDON & SAN FRANCISCO, July 22, 2025--(BUSINESS WIRE)--Today, Latent Labs is launching Latent-X, a frontier AI model for push button protein design, outperforming competing models under identical laboratory conditions. The model is available for early access on Latent's no-code AI protein design platform, where users can upload protein targets and generate cyclic peptides and mini-binders directly in the browser. Through the platform, users can generate, explore, and score binder designs, selecting top-ranked structures for further lab testing. The platform includes a free tier for both commercial and non-commercial users. Sign up is available at Latent Labs is a frontier AI lab working to transform the expensive, labor intensive, and high failure rate processes of drug discovery into automated drug design. Traditional drug discovery requires screening millions of random molecules—a process where hit rates are typically well below 1% and each experiment takes months and costs thousands of dollars. With Latent-X, drug designers can generate high-confidence binders with the push of a button, achieving what would typically require testing millions of candidates by testing as little as 30 candidates per target. AI models have recently enabled solutions to previously insurmountable technical challenges in biology. With generative models, frontier AI can go beyond predicting structures to creating new sequences and structures of candidate drugs. "We envision a future where effective therapeutics can be designed entirely in a computer, much like how space missions or semiconductors are designed today," said Simon Kohl, CEO and founder of Latent Labs. "Our platform empowers scientists with lab-validated protein binder design at their fingertips, whether they're experts or new to AI-powered drug design, and without needing AI infrastructure. This is the first step on our mission toward making biology programmable in order to make drug design instantaneous." Latent-X generates functional, high affinity de novo binders with breakthrough laboratory performance. In extensive wet lab experiments across 7 therapeutic targets, Latent-X achieved 91-100% hit rates for macrocycles and 10-64% hit rates for mini-binders. The model delivered picomolar binding affinities for mini-binders and single-digit micromolar affinities for macrocycles, with generated binders showing strong target specificity. In head-to-head experimental comparisons, Latent-X exceeded the prior state-of-the-art, outperforming existing generative tools in both in silico evaluations and laboratory validation. Macrocycles are a sought after drug modality for their potential oral deliverability, with their compactness promising tissue permeability while retaining specificity. Mini-binders are a versatile new binder modality that offers high specificity in a flexible format. Full results are available in our technical report: The Latent Labs Platform allows users to access the state of the art in protein binder design in an intuitive platform for target upload, hotspot selection, binder design, and computational ranking. The platform features structure visualization, predicted structure overlays, and computational metric rankings allowing to replicate the AI workflows used to generate our successfully lab-validated binders. Latent-X is a general purpose frontier model that creates binders from scratch for unseen or previously untargeted proteins, solving the geometric puzzle of binding at the all-atom level. The model generates designs over 10x faster than previous methods and co-samples sequence and structure simultaneously, allowing for computational experimentation within seconds. Latent-X generalizes beyond nature's repertoire by generating all-atom binder structures that obey atomic-level biochemical rules, opening doors to other therapeutic modalities that depend on target-specific binding—nanobodies and antibodies being prime examples. The company is now open to partnerships to bring these expanded capabilities to new drug applications. Only five months ago Latent Labs announced its $50M funding round co-lead by Radical Ventures and Sofinnova Partners, with participation by Google's Chief Scientist Jeff Dean, Anthropic's CEO Dario Amodei and Eleven Labs' CEO Mati Staniszewski. The team consists of former AlphaFold 2 co-developers, ex-DeepMind team leads, and brings rich experience from Microsoft, Apple, Stability AI, Exscientia, Mammoth Bio, Altos Labs and Zymergen. View source version on Contacts contact@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store